Takeda
TAK · NYSE
Bulios Fair Price
$22.08
20.9% upside
Current Price
$18.27
According to Bulios Fair Price, TAK is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Takeda Pharmaceutical Company Ltd. (Takeda) is a Japanese pharmaceutical company headquartered in Tokyo. Takeda is one of the largest pharmaceutical companies in the world and has a global presence. The company focuses on research, development, and manufacturing of pharmaceutical products in various therapeutic areas, including oncology, gastroenterology, neuroscience, and more. Takeda is committed to innovation and improving the health of people worldwide. Takeda Pharmaceutical Company Ltd. shares may be suitable for investors seeking opportunities in the pharmaceutical sector and monitoring developments in drug research and disease treatment.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Julie So-Young Kim
Employees
47,029
Headquarters
Tokyo
Upcoming events
Earnings
Upcoming earnings report